SpyGlass Pharma Inc. Common Stock
SGP | NASDAQ
$32.39
-$0.12 (-0.37%)
At close: Oct 30, 2026, 3:59 PM ET
$32.24
-$0.15 (-0.46%)
After-hours:
Oct 30, 2026, 7:30 PM ET
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 |
|---|---|---|---|---|
Net Income | -56.05M | -36.19M | -22.37M | -9.82M |
Depreciation & Amortization | 1.01M | 672K | 354K | 137.27K |
Stock-Based Compensation | 1.85M | 1.85M | 1.85M | 931.75K |
Other Working Capital | 1.81M | 66K | 2.55M | 994.29K |
Other Non-Cash Items | 3.51M | 1.3M | -408K | 70.87K |
Deferred Income Tax | n/a | n/a | n/a | n/a |
Change in Working Capital | 3.12M | 645K | 2.4M | -164.95K |
Operating Cash Flow | -46.56M | -31.72M | -18.18M | -8.84M |
Capital Expenditures | -3.18M | -1.25M | -573K | -152.51K |
Cash Acquisitions | n/a | n/a | n/a | n/a |
Purchase of Investments | -28M | -21M | -17M | -12M |
Sales Maturities Of Investments | 17M | 9.01M | 6M | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a |
Investing Cash Flow | -14.18M | -13.25M | -11.58M | -12.15M |
Debt Repayment | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -1.18M | -1.18M | -1.18M | -273.23K |
Financial Cash Flow | 156.64M | 156.63M | -1.12M | -234.36K |
Net Cash Flow | 95.91M | 111.67M | -30.88M | -21.23M |
Free Cash Flow | -49.74M | -32.97M | -18.75M | -8.99M |
Adj. Free Cash Flow | -51.59M | -34.82M | -20.6M | -9.93M |
Maintenance CapEx | -1.01M | n/a | n/a | n/a |
Growth CapEx | -2.17M | n/a | n/a | n/a |
Owner Earnings | -47.57M | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove SGP